Position
SIMPLEX TRADING, LLC in Fulcrum Therapeutics, Inc.
Back to the book · All holders of FULC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$29.2K$11.31 → $7.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 8.01K | $90.6K | — | — | — | 0.0% |
| Q1 2026 | 41.9K | $321.7K | $7.67 | −$29.2K | $260.2K | 0.0% |